Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Waldenstrom Macroglobulinemia 1Myasthenia Gravis 1Multiple Myeloma 1

Interventions

telitacicept 3rozanolixizumab 3talquetamab 1ravulizumab 1efgartigimod alfa 1blinatumomab 1Therapeutics 1Pyridostigmine Bromide 1Psychodrama 1Prednisone 1Population Groups 1Art Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Myasthenia Gravis × talquetamab × Clear all
NCT07499323 2026-04-08

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

First Affiliated Hospital of Chongqing Medical University

Phase NA Not yet recruiting
2 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡